tiprankstipranks
Trending News
More News >
Nakanishi (JP:7716)
:7716
Advertisement

Nakanishi (7716) AI Stock Analysis

Compare
0 Followers

Top Page

JP:7716

Nakanishi

(Frankfurt:7716)

Rating:73Outperform
Price Target:
¥2,178.00
▲(10.39%Upside)
Nakanishi's overall stock score is bolstered by strong financial performance, marked by significant revenue growth and effective cash management. Technical analysis supports a stable upward trend, although the valuation indicates a relatively high P/E ratio. The absence of earnings call insights and corporate events data leaves these aspects unconsidered.

Nakanishi (7716) vs. iShares MSCI Japan ETF (EWJ)

Nakanishi Business Overview & Revenue Model

Company DescriptionNakanishi Inc. is a Japanese company specializing in the manufacturing and distribution of high-precision rotary cutting instruments and equipment. The company primarily operates in the dental and industrial sectors, providing a wide range of products such as dental handpieces, micro-motors, surgical instruments, and industrial precision tools. With a commitment to innovation and quality, Nakanishi aims to enhance the productivity and efficiency of its customers across various industries.
How the Company Makes MoneyNakanishi Inc. generates revenue through the sale of its precision instruments and equipment to dental professionals and industrial clients globally. The company's revenue streams are largely driven by the production and distribution of dental handpieces and related products, which are essential tools in dental practices and surgeries. Additionally, Nakanishi capitalizes on its industrial precision tools, serving sectors such as electronics and automotive manufacturing. The company's earnings are supported by its strong global distribution network and strategic partnerships with local distributors and dental equipment manufacturers, enabling it to reach a wide customer base. By continuously investing in research and development, Nakanishi maintains its competitive edge, ensuring a steady flow of innovative products that meet the evolving needs of its clients.

Nakanishi Financial Statement Overview

Summary
Nakanishi exhibits strong financial health with significant revenue growth and efficient cash flow management. The company maintains a robust balance sheet with low leverage, though the recent decline in net income impacts profitability metrics. Continued focus on operational efficiency and cost management can sustain its positive trajectory.
Income Statement
85
Very Positive
Nakanishi shows strong revenue growth with a notable increase of 29.05% from 2023 to 2024, indicating a healthy business expansion. The gross profit margin is robust at 57.66% for 2024, suggesting efficient production and cost management. Despite a decline in net income from 2023 to 2024, the net profit margin remains solid at 11.13%. EBIT and EBITDA margins are strong at 18.94% and 26.55% respectively, showcasing operational efficiency.
Balance Sheet
78
Positive
Nakanishi maintains a strong equity base with an equity ratio of 76.55% in 2024, indicating financial stability and low leverage. The debt-to-equity ratio is low at 0.15, reflecting prudent debt management. However, there is a significant decline in net income impacting the ROE, which stands at 7.08% for 2024, down from previous years.
Cash Flow
82
Very Positive
The company demonstrates impressive free cash flow growth of 287.01% from 2023 to 2024, highlighting effective cash generation. The operating cash flow to net income ratio is 1.78, indicating strong cash conversion. The free cash flow to net income ratio is 1.17, reflecting efficient capital expenditure management. However, the operating cash flow growth is moderate compared to revenue growth.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue77.04B59.69B48.67B44.86B33.06B
Gross Profit44.42B36.09B31.22B27.30B19.73B
EBITDA19.59B32.30B19.40B15.80B10.88B
Net Income8.58B22.80B12.47B10.10B6.46B
Balance Sheet
Total Assets158.30B140.71B102.15B94.46B82.47B
Cash, Cash Equivalents and Short-Term Investments47.11B32.65B36.18B37.41B33.67B
Total Debt18.73B11.67B480.80M100.00M100.00M
Total Liabilities37.10B27.51B11.13B11.54B6.20B
Stockholders Equity121.19B113.19B91.02B82.92B76.27B
Cash Flow
Free Cash Flow10.05B2.60B3.78B9.62B7.99B
Operating Cash Flow15.30B8.56B7.76B11.97B9.18B
Investing Cash Flow-7.94B-19.15B-6.31B-4.15B-1.38B
Financing Cash Flow598.51M3.41B-6.11B-3.97B-2.69B

Nakanishi Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1973.00
Price Trends
50DMA
1888.71
Positive
100DMA
1921.21
Positive
200DMA
2168.64
Negative
Market Momentum
MACD
19.97
Negative
RSI
61.32
Neutral
STOCH
68.25
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7716, the sentiment is Positive. The current price of 1973 is above the 20-day moving average (MA) of 1926.35, above the 50-day MA of 1888.71, and below the 200-day MA of 2168.64, indicating a neutral trend. The MACD of 19.97 indicates Negative momentum. The RSI at 61.32 is Neutral, neither overbought nor oversold. The STOCH value of 68.25 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7716.

Nakanishi Peers Comparison

Overall Rating
UnderperformOutperform
Sector (52)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
$139.14B16.166.55%3.78%2.42%-13.12%
76
Outperform
$181.46B12.8910.34%2.78%7.49%9.71%
73
Outperform
¥167.63B29.314.78%2.64%20.53%-75.16%
72
Outperform
¥127.83B23.12
3.01%5.82%-20.09%
61
Neutral
¥72.90B16.81
2.42%15.55%42.14%
57
Neutral
€223.20B43.082.07%2.32%9.85%-53.97%
52
Neutral
$7.60B0.11-62.95%2.07%16.16%0.31%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7716
Nakanishi
1,973.00
-527.91
-21.11%
JP:7730
Mani, Inc.
1,265.50
-783.82
-38.25%
JP:7979
Shofu Inc.
2,021.00
-304.45
-13.09%
JP:8086
Nipro
1,381.50
105.84
8.30%
JP:3360
Ship Healthcare Holdings
2,082.00
-118.81
-5.40%
JP:7817
Paramount Bed Holdings Co
2,566.00
35.94
1.42%

Nakanishi Corporate Events

Nakanishi Inc. Updates on Share Repurchase Program
Jul 1, 2025

Nakanishi Inc. announced the status of its share repurchase program, resolved in February 2025, aiming to repurchase up to 2,000,000 common shares by the end of December 2025. As of June 30, 2025, the company has repurchased 1,084,100 shares, reflecting a significant step in its financial strategy, impacting its market positioning and shareholder value.

Nakanishi Inc. Updates on Share Repurchase Program
Jun 2, 2025

Nakanishi Inc. announced the status of its share repurchase program, which was resolved in a Board of Directors meeting in February 2025. The company has repurchased 1,084,100 shares at a cost of JPY 2,253,016,800 as of May 31, 2025, with plans to repurchase up to 2,000,000 shares by the end of the year. This move is part of Nakanishi’s strategy to enhance shareholder value and optimize its capital structure.

Nakanishi Finalizes Stock Option Terms for Directors
May 30, 2025

Nakanishi Inc. has finalized the terms for issuing compensation-type stock options to three of its directors, with a total of 15 units being allocated. This decision, resolved at a board meeting, reflects the company’s commitment to aligning executive incentives with its strategic goals, potentially impacting its operational focus and stakeholder interests.

Nakanishi Inc. Issues Stock Options to Align Director Compensation with Performance
May 12, 2025

Nakanishi Inc. has announced the issuance of stock acquisition rights as compensation-type stock options for its directors, aiming to align director compensation with business performance and shareholder interests. This strategic move is expected to strengthen the company’s operational efficiency and market positioning by incentivizing its leadership team.

Nakanishi Inc. Revises Financial Forecasts Following Tax Audit
May 12, 2025

Nakanishi Inc. plans to file an amended tax return following a tax audit by the KantoShinetsu Regional Taxation Bureau, which identified that certain overseas subsidiaries should be taxed in Japan. This has led to a revision of the company’s financial forecasts for the fiscal year ending December 31, 2025, with a decrease in profit attributable to owners of the parent due to additional income taxes. Despite this, the dividend forecast remains unchanged. The company is taking steps to improve its tax compliance framework and is monitoring the potential impact of U.S. tariff policies on its business.

Nakanishi Inc. Faces Financial Challenges in Q1 2025
May 12, 2025

Nakanishi Inc. reported a challenging first quarter for 2025, with a decline in key financial metrics compared to the previous year. The company experienced a decrease in net sales, operating income, and ordinary income, with income attributable to owners of the parent dropping significantly. Despite these setbacks, Nakanishi maintains a strong equity ratio and has forecasted a slight increase in annual dividends, indicating a cautious optimism for the remainder of the year.

Nakanishi Inc. Updates on Share Repurchase Program
May 1, 2025

Nakanishi Inc. announced the status of its share repurchase program, which was resolved at the Board of Directors meeting on February 12, 2025. The company repurchased 246,600 shares in April 2025 at a cost of JPY 449,986,600, with a plan to repurchase up to 2,000,000 shares by the end of the year. This move is part of Nakanishi’s strategy to enhance shareholder value and reflects its strong financial position.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 24, 2025